Literature DB >> 19146203

Effectiveness and safety of vaginal suppositories for the treatment of the vaginal atrophy in postmenopausal women: an open, non-controlled clinical trial.

D Costantino1, C Guaraldi.   

Abstract

Menopause, due to the physiological decrease in the estrogens levels, is often associated with many symptoms related to vaginal atrophy such vaginal dryness, dyspareunia, burning, itching, decreasing in libido and therefore a worsening of the quality of life and in particular of the sexual activity. There are many pharmacological remedies to solve these events, first of all hormone replacement therapy (HRT) that up to the 90s was the therapy of choice for the care of the menopause symptoms. This hormonal therapy, however, has been re-considered due to its side effects. As alternative, a clinical trial has been performed to investigate the efficacy and safety, in postmenopausal women with urogenital atrophy, of the use of suppositories for vaginal use, containing hyaluronic acid, vitamin E and vitamin A. The trial, according to a open, non-controlled design, was performed on 150 postmenopausal women, 1 vaginal suppository per day, for the first 14 days and then a vaginal suppository, day in and day out, for other 14 days. The primary endpoint was the evaluation of vaginal dryness assessed by a Visual Analogue Scale (VAS) both by the investigator and the patient. The secondary endpoints were the evaluation of all the other symptoms and signs associated with the vaginal atrophy (itching, burning, dyspareunia, vaginal inflammation or swelling, irritation, assessed by a 4-point scale, presence of vaginal abrasions and irritation), and the recording of the adverse events occurring during the trial. The patients have not reported adverse effects during the treatment, and the results in terms of effectiveness on the vaginal atrophy symptoms were markedly positive. A high level of compliance was registered. The product tested can therefore be considered a safe and effective alternative for the treatment of vaginal atrophy symptoms in postmenopausal women, especially when HRT is not recommended.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19146203

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  20 in total

1.  A single-arm clinical trial investigating the effectiveness of a non-hormonal, hyaluronic acid-based vaginal moisturizer in endometrial cancer survivors.

Authors:  Jeanne Carter; Shari Goldfarb; Raymond E Baser; Deborah J Goldfrank; Barbara Seidel; Lisania Milli; Sally Saban; Cara Stabile; Jocelyn Canty; Ginger J Gardner; Elizabeth L Jewell; Yukio Sonoda; Marisa A Kollmeier; Kaled M Alektiar
Journal:  Gynecol Oncol       Date:  2020-06-08       Impact factor: 5.482

Review 2.  Sjögren Syndrome and Other Causes of Sicca in Older Adults.

Authors:  Alan N Baer; Brian Walitt
Journal:  Clin Geriatr Med       Date:  2017-02       Impact factor: 3.076

Review 3.  Update on Sjögren Syndrome and Other Causes of Sicca in Older Adults.

Authors:  Alan N Baer; Brian Walitt
Journal:  Rheum Dis Clin North Am       Date:  2018-08       Impact factor: 2.670

Review 4.  How to ask and what to do: a guide for clinical inquiry and intervention regarding female sexual health after cancer.

Authors:  Sharon L Bober; Jennifer B Reese; Lisa Barbera; Andrea Bradford; Kristen M Carpenter; Shari Goldfarb; Jeanne Carter
Journal:  Curr Opin Support Palliat Care       Date:  2016-03       Impact factor: 2.302

Review 5.  Sexual health as a survivorship issue for female cancer survivors.

Authors:  Don S Dizon; Daphne Suzin; Susanne McIlvenna
Journal:  Oncologist       Date:  2014-01-06

Review 6.  Reproductive health care across the lifecourse of the female cancer patient.

Authors:  Lisa A Rubinsak; Mindy S Christianson; Aletha Akers; Jeanne Carter; Andrew M Kaunitz; Sarah M Temkin
Journal:  Support Care Cancer       Date:  2018-07-26       Impact factor: 3.603

7.  Vaginal and sexual health treatment strategies within a female sexual medicine program for cancer patients and survivors.

Authors:  Jeanne Carter; Cara Stabile; Barbara Seidel; Raymond E Baser; Shari Goldfarb; Deborah J Goldfrank
Journal:  J Cancer Surviv       Date:  2016-11-21       Impact factor: 4.442

8.  Transcription, translation, and function of lubricin, a boundary lubricant, at the ocular surface.

Authors:  Tannin A Schmidt; David A Sullivan; Erich Knop; Stephen M Richards; Nadja Knop; Shaohui Liu; Afsun Sahin; Raheleh Rahimi Darabad; Sheila Morrison; Wendy R Kam; Benjamin D Sullivan
Journal:  JAMA Ophthalmol       Date:  2013-06       Impact factor: 7.389

Review 9.  Maintaining sexual health throughout gynecologic cancer survivorship: A comprehensive review and clinical guide.

Authors:  Laura B Huffman; Ellen M Hartenbach; Jeanne Carter; Joanne K Rash; David M Kushner
Journal:  Gynecol Oncol       Date:  2015-11-07       Impact factor: 5.482

10.  A single-arm, prospective trial investigating the effectiveness of a non-hormonal vaginal moisturizer containing hyaluronic acid in postmenopausal cancer survivors.

Authors:  Jeanne Carter; Raymond E Baser; Deborah J Goldfrank; Barbara Seidel; Lisania Milli; Cara Stabile; Jocelyn Canty; Sally Saban; Shari Goldfarb; Maura N Dickler; Ginger J Gardner; Elizabeth L Jewell; Yukio Sonoda; Marisa A Kollmeier; Kaled M Alektiar
Journal:  Support Care Cancer       Date:  2020-05-02       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.